Hello, Fool! | Login | Signup | My Fool
Jul 24, 2008 9:31 AM ET | Site Changes | Help
A biopharmaceutical company which advances oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers.
View Ticker Page (IMCL)
Results 11 - 20 of 40 : 1234
Recs
SnakPak (< 20) Submitted: 10/14/07 2:33 AM : Start Price: $45.51 IMCL Score: 18.77
Just a hunch. Also, high execs bought a lot of their own stock.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
prosper21 (< 20) Submitted: 1/06/08 1:25 PM : Start Price: $40.64 IMCL Score: 22.48
Up coming presentation of Phase 3 data from Flex Study around June 2008 ASCO conference shouldmake this stocks a great speculative buy.not to mention a great pipeline and great chance of a buy out.
Fishlip98 (33.03) Submitted: 1/08/08 8:42 PM : Start Price: $38.59 IMCL Score: 26.71
as the baby boomers age and the wonder cancer drugthat they now own outright will take this baby to the 60's
MattCraig (98.84) Submitted: 7/21/08 8:22 AM : Start Price: $46.97 IMCL Score: -3.72
will takeover focus sweep group after DNA?
mdriver78 (< 20) Submitted: 6/02/08 5:33 AM : Start Price: $40.50 IMCL Score: 21.59
From a Reuters report, "researchers claim another step closer to the "Holy Grail" of so-called personalized medicine, whereby information about a patient's genotype is used to select medication.The study, looking at a subset...
wundermichl (22.45) Submitted: 5/13/08 12:14 PM : Start Price: $43.03 IMCL Score: 15.15
Cetuximab (Erbitux) will most likely be approved for treatment of non-small cell lung cancer. The recent downgrade by a Morgan Stanley analyst was probably derived from speculation and not actual data of the FLEX study. Extrapolating data from the ...
Report this Post Replies: 1 | Reply | Permalink
evillate (< 20) Submitted: 5/01/08 6:44 PM : Start Price: $48.18 IMCL Score: 4.45
Competitors drug showed that it did not help. I'll ride that for a little while.
Cosmo21 (33.94) Submitted: 4/21/08 8:46 PM : Start Price: $48.72 IMCL Score: 1.31
Good news!
mchuley (< 20) Submitted: 1/18/08 5:18 PM : Start Price: $40.72 IMCL Score: 11.89
i see the stock doubling by end of the year, egg on my face, we will see how i feel by summer, but the data is gonna be a shocker and well thumbs up
csmith201 (99.47) Submitted: 4/20/07 3:20 PM : Start Price: $41.85 IMCL Score: 23.03
Good pipline...Waiting on PIII of Erbitux
Terms & Conditions
RSS Headlines
Fool UK